These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28683787)

  • 21. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors.
    Walsh BW
    Ann N Y Acad Sci; 2001 Dec; 949():163-7. PubMed ID: 11795349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging hormonal treatments for menopausal symptoms.
    Genazzani AR; Komm BS; Pickar JH
    Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update.
    Meziou N; Scholfield C; Taylor CA; Armstrong HL
    Menopause; 2023 Jun; 30(6):659-671. PubMed ID: 37159867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.
    Nelson HD; Walker M; Zakher B; Mitchell J
    Ann Intern Med; 2012 Jul; 157(2):104-13. PubMed ID: 22786830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the role of oestrogen in the prevention of cardiovascular disease.
    Nair GV; Klein KP; Herrington DM
    Ann Med; 2001 Jul; 33(5):305-12. PubMed ID: 11491187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of a phyto-SERM as an alternative to hormone therapy.
    Sánchez-Borrego R; Navarro MC; Llaneza P; Hormigo A; Duran M; Mendoza N
    Climacteric; 2015 Jun; 18(3):350-7. PubMed ID: 25236805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis.
    Aleksova J; Rodriguez AJ; McLachlan R; Kerr P; Milat F; Ebeling PR
    Curr Osteoporos Rep; 2018 Dec; 16(6):674-692. PubMed ID: 30328552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmenopausal hormone therapy: the way ahead.
    Pines A
    Maturitas; 2007 May; 57(1):3-5. PubMed ID: 17376615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Gartlehner G; Patel SV; Feltner C; Weber RP; Long R; Mullican K; Boland E; Lux L; Viswanathan M
    JAMA; 2017 Dec; 318(22):2234-2249. PubMed ID: 29234813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials.
    Casanova G; Bossardi Ramos R; Ziegelmann P; Spritzer PM
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1028-37. PubMed ID: 25514104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
    Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG
    Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
    Mijatovic V; van der Mooren MJ
    Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone replacement therapy trials: an update.
    Duvernoy CS; Mosca L
    Curr Atheroscler Rep; 2002 Mar; 4(2):156-60. PubMed ID: 11822980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy for menopausal women.
    Moghissi KS
    Compr Ther; 2000; 26(3):197-202. PubMed ID: 10984825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of hormone replacement therapy in postmenopausal women.
    Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
    J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
    Burckhardt P
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1926-30. PubMed ID: 10635085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.